Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2022 Financial Results Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against core elements of our Roche-Genentech...